To continue reading this article, you must log in with your personal, organization, or group practice subscription.
For more information or to purchase a personal subscription, click below to see pricing.
An analysis of 8 double-blind, randomized trials on rofecoxib vs. NSAIDs in osteoarthritis patients assessed the incidence of upper GI tract perforations, symptomatic gastroduodenal ulcers, and upper GI tract bleedings (PUBs)
To continue reading this article, you must log in with your personal, organization, or group practice subscription.
For more information or to purchase a personal subscription, click below to see pricing.
|
|